Menu
23/08/2005
Doctors issue warning over ad hoc screenings
Patients are being warned against using unregulated or ad hoc screening tests in a new report, published by the British Medical Association.
The report, from the BMA’s Board of Science, warns that unregulated tests may cause more harm than good and give inconsistent results.
The BMA said that the public should be “extremely wary” of unregulated screening, especially test kits than can be purchased via the internet or mail order.
The report warned that unregulated screening could put patients at risk, because the tests were unlikely to be based on sound evidence, have non-existent quality control and lack balanced information for patients. The report also warned that such tests were unlikely to include information and support for patients, in the event of a positive result.
Ad hoc screenings could result in false results, which could lead to potentially dangerous further investigations in ‘positive’ cases and possible delayed diagnosis in ‘negative’ cases, the BMA warned.
They could also lead to over-detection of latent disease, which could lead to treatment with possible side effects, for conditions that would not have caused a problem.
The BMA report highlighted a number of unregulated screening tests, which could pose problems.
Unregulated whole body CT scanning could lead many false alarms and also involved significant does of radiation. The BMA also warned that there was no evidence to suggest that CT screening is useful for people without symptoms, in spite of it being offered and promoted by some commercial companies.
Exercise electrocardiograms (ECG) were also criticised and the BMA warned that they were far more likely to give a false result if given to people without symptoms of heart disease.
Breast screening x-rays (mammograms), which are used to detect cancers in women over 50, were deemed unsuitable for detecting small cancers in women under 50. This could lead to further invasive tests and the possibility of surgery for women whose cancers may not have progressed during their lifetime.
This is why the NHS Breast Screening Programme offers screening for women aged between 50 and 70 only, the BMA said.
Prostate Specific Antigen (PSA) testing was also criticised. The BMA said that two thirds of men with high PSA did not have prostate cancer, while some men with prostate cancer did not have high PSA. The report said there was also no evidence to show whether treating localised prostate cancer did more harm than good.
The BMA report also criticised some aspects of private sector screening, saying there were “important concerns” about harms from inappropriate tests, lack of continuity of care, quality assurance and lack of support and advice, particularly in the area of genetic testing.
The BMA has called for the government to address the issues of ad hoc screening and improve the information available about formal screening programmes.
Commenting on the report, Dr Vivienne Nathanson, the BMA’s Head of Science and Ethics, said: “There is no doubt that some specific screening tests have the potential to save lives, but this does not mean that there are no associated risks. We must make sure that screening is of a high quality and that patients are given all the appropriate advice before they decide to participate.
(KMcA/SP)
The report, from the BMA’s Board of Science, warns that unregulated tests may cause more harm than good and give inconsistent results.
The BMA said that the public should be “extremely wary” of unregulated screening, especially test kits than can be purchased via the internet or mail order.
The report warned that unregulated screening could put patients at risk, because the tests were unlikely to be based on sound evidence, have non-existent quality control and lack balanced information for patients. The report also warned that such tests were unlikely to include information and support for patients, in the event of a positive result.
Ad hoc screenings could result in false results, which could lead to potentially dangerous further investigations in ‘positive’ cases and possible delayed diagnosis in ‘negative’ cases, the BMA warned.
They could also lead to over-detection of latent disease, which could lead to treatment with possible side effects, for conditions that would not have caused a problem.
The BMA report highlighted a number of unregulated screening tests, which could pose problems.
Unregulated whole body CT scanning could lead many false alarms and also involved significant does of radiation. The BMA also warned that there was no evidence to suggest that CT screening is useful for people without symptoms, in spite of it being offered and promoted by some commercial companies.
Exercise electrocardiograms (ECG) were also criticised and the BMA warned that they were far more likely to give a false result if given to people without symptoms of heart disease.
Breast screening x-rays (mammograms), which are used to detect cancers in women over 50, were deemed unsuitable for detecting small cancers in women under 50. This could lead to further invasive tests and the possibility of surgery for women whose cancers may not have progressed during their lifetime.
This is why the NHS Breast Screening Programme offers screening for women aged between 50 and 70 only, the BMA said.
Prostate Specific Antigen (PSA) testing was also criticised. The BMA said that two thirds of men with high PSA did not have prostate cancer, while some men with prostate cancer did not have high PSA. The report said there was also no evidence to show whether treating localised prostate cancer did more harm than good.
The BMA report also criticised some aspects of private sector screening, saying there were “important concerns” about harms from inappropriate tests, lack of continuity of care, quality assurance and lack of support and advice, particularly in the area of genetic testing.
The BMA has called for the government to address the issues of ad hoc screening and improve the information available about formal screening programmes.
Commenting on the report, Dr Vivienne Nathanson, the BMA’s Head of Science and Ethics, said: “There is no doubt that some specific screening tests have the potential to save lives, but this does not mean that there are no associated risks. We must make sure that screening is of a high quality and that patients are given all the appropriate advice before they decide to participate.
(KMcA/SP)
Related UK National News Stories
Click here for the latest headlines.
28 November 2008
Down's Syndrome Screening Examined
A new screening strategy has halved the number of infants born with Down's syndrome and increased the number diagnosed before birth by 30%, according to a study published on the British Medical Journal's website, bmj.com, today.
Down's Syndrome Screening Examined
A new screening strategy has halved the number of infants born with Down's syndrome and increased the number diagnosed before birth by 30%, according to a study published on the British Medical Journal's website, bmj.com, today.
02 July 2003
Charity outlines guidelines for cervical screenings
All women aged between 25 and 49 should be offered cervical screening every three years – but five years is regular enough for women aged 50 to 64 – according to a new report by Cancer Research UK.
Charity outlines guidelines for cervical screenings
All women aged between 25 and 49 should be offered cervical screening every three years – but five years is regular enough for women aged 50 to 64 – according to a new report by Cancer Research UK.
17 June 2009
Wealth And Ethnicity 'Linked To Whether Women Have Breast And Cervical Screening'
White British women are more likely to have had a cervical screening and there is more chance that women who own a car and/or home have had a mammogram, according to research published on bmj.com today.
Wealth And Ethnicity 'Linked To Whether Women Have Breast And Cervical Screening'
White British women are more likely to have had a cervical screening and there is more chance that women who own a car and/or home have had a mammogram, according to research published on bmj.com today.
30 October 2012
Breast Cancer Screening Leads To 'Over Diagnoses'
Women are to be nformed over breast cancer screening issues in the UK after a review highlights the potential harms of being tested. The review panel, led by Prof Michael Marmot, from University College London, found screening had "contributed to reducing deaths" but also "resulted in some overdiagnosis".
Breast Cancer Screening Leads To 'Over Diagnoses'
Women are to be nformed over breast cancer screening issues in the UK after a review highlights the potential harms of being tested. The review panel, led by Prof Michael Marmot, from University College London, found screening had "contributed to reducing deaths" but also "resulted in some overdiagnosis".
24 July 2007
Cancer test kit 'could lead to 20,000 fewer deaths'
Deaths from bowel cancer could be dramatically reduced if people use a self-testing kit being sent to people in their sixties throughout the country, a cancer charity has predicted.
Cancer test kit 'could lead to 20,000 fewer deaths'
Deaths from bowel cancer could be dramatically reduced if people use a self-testing kit being sent to people in their sixties throughout the country, a cancer charity has predicted.
-
Northern Ireland WeatherToday:A showery start with outbreaks most frequent north of Lough Neagh and through the morning, before dwindling during the afternoon as the northwest breezes ease and brighter spells of weak sunshine prosper. Maximum temperature 8 °C.Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.
